iShares Nasdaq Biotechnology ETF (IBB) Experiences Big Inflow

Share This Article
December 10, 2018 1:31pm NASDAQ:IBB

NASDAQ:IBB | News, Ratings, and Charts

From ETF Channel: Exchange traded funds (ETFs) trade just like stocks, but instead of ”shares” investors are actually buying and selling ”units”. These ”units” can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. 


Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while the destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology ETF (IBB) where we have detected an approximate $217.3 million dollar inflow — that’s a 2.7% increase week over week in outstanding units (from 76,600,000 to 78,700,000). Among the largest underlying components of IBB, in trading today Amgen Inc (AMGN) is down about 0.4%, Biogen Inc (BIIB) is up about 0.1%, and Celgene Corp (CELG)is lower by about 2.3%. For a complete list of holdings, visit the IBB Holdings page »

The chart below shows the one year price performance of IBB, versus its 200 day moving average:

Looking at the chart above, IBB’s low point in its 52 week range is $100.221 per share, with $122.97 as the 52 week high point — that compares with a last trade of $102.83. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique


The iShares Nasdaq Biotechnology ETF (IBB) was trading at $103.08 per share on Monday afternoon, down $0.56 (-0.54%). Year-to-date, IBB has declined -3.46%, versus a -1.38% rise in the benchmark S&P 500 index during the same period.

IBB currently has an ETF Daily News SMART Grade of A (Strong Buy), and is ranked #2 of 34 ETFs in the Health & Biotech ETFs category.


This article is brought to you courtesy of ETF Channel.


7 "SAFE HAVEN" Dividend Stocks for Turbulent Times

Read Next



Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

Most Popular



7 Best ETFs for the NEXT Bull Market

Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories